These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8615619)
41. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. Kyritsis A; Joseph G; Chader GJ J Natl Cancer Inst; 1984 Sep; 73(3):649-54. PubMed ID: 6590911 [TBL] [Abstract][Full Text] [Related]
42. All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas. Miller WH; Maerz WJ; Kurie J; Moy D; Baselga J; Lucas DA; Grippo JF; Masui H; Dmitrovsky E Differentiation; 1994 Jan; 55(2):145-52. PubMed ID: 8143931 [TBL] [Abstract][Full Text] [Related]
43. Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro. Spencer SJ; Rabinovici J; Jaffe RB J Clin Endocrinol Metab; 1990 Dec; 71(6):1678-80. PubMed ID: 2229325 [TBL] [Abstract][Full Text] [Related]
44. Activin A induces terminal differentiation of cultured human keratinocytes. Seishima M; Nojiri M; Esaki C; Yoneda K; Eto Y; Kitajima Y J Invest Dermatol; 1999 Apr; 112(4):432-6. PubMed ID: 10201525 [TBL] [Abstract][Full Text] [Related]
45. Activin inhibits cell growth and induces differentiation in human retinoblastoma y79 cells. Kanno C; Kashiwagi Y; Horie K; Inomata M; Yamamoto T; Kitanaka C; Yamashita H Curr Eye Res; 2009 Aug; 34(8):652-9. PubMed ID: 19899992 [TBL] [Abstract][Full Text] [Related]
47. [Changes in various differentiation-related makers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide (HMBA)]. Tanaka T Nihon Sanka Fujinka Gakkai Zasshi; 1992 Apr; 44(4):513. PubMed ID: 1607777 [No Abstract] [Full Text] [Related]
48. Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. Rabinovici J; Spencer SJ; Jaffe RB J Clin Endocrinol Metab; 1990 Nov; 71(5):1396-8. PubMed ID: 2229297 [TBL] [Abstract][Full Text] [Related]
51. Modulation of retinoblastoma cell characteristics by hexamethylene bis-acetamide and other differentiating agents in culture. Rajagopalan S; Rodrigues M; Polk T; Wilson D; Chader GJ; Hayden BJ J Histochem Cytochem; 1993 Sep; 41(9):1331-7. PubMed ID: 8394854 [TBL] [Abstract][Full Text] [Related]
52. Activin/EDF as an inhibitor of neural differentiation. Hashimoto M; Kondo S; Sakurai T; Etoh Y; Shibai H; Muramatsu M Biochem Biophys Res Commun; 1990 Nov; 173(1):193-200. PubMed ID: 2256914 [TBL] [Abstract][Full Text] [Related]
53. An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide. Subramanyam B; Callery PS; Egorin MJ; Snyder SW; Conley BA Drug Metab Dispos; 1989; 17(4):398-401. PubMed ID: 2571479 [TBL] [Abstract][Full Text] [Related]
54. Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA. Li QF; Tang J; Liu QR; Shi SL; Chen XF Cancer Invest; 2010 Dec; 28(10):1004-12. PubMed ID: 20690796 [TBL] [Abstract][Full Text] [Related]
55. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP. Khan MZ; Freshney RI; McNicol AM; Murray AM Ann Oncol; 1993 Jun; 4(6):499-507. PubMed ID: 8394737 [TBL] [Abstract][Full Text] [Related]
56. Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro. Kong XB; Fanucchi MP; Chou TC Leuk Res; 1988; 12(10):853-9. PubMed ID: 3199844 [TBL] [Abstract][Full Text] [Related]
57. Predominant melanogenesis and lentoidogenesis in vitro from multipotent pineal cells by dimethyl sulfoxide and hexamethylene bisacetamide. Orii H; Hyuga M; Mochii M; Kosaka J; Eguchi G; Watanabe K Int J Dev Biol; 1994 Jun; 38(2):397-404. PubMed ID: 7981050 [TBL] [Abstract][Full Text] [Related]
58. Control of retinoblastoma cell growth by differentiating agents: current work and future directions. Kyritsis AP; Tsokos M; Chader GJ Anticancer Res; 1986; 6(3 Pt B):465-73. PubMed ID: 2427007 [TBL] [Abstract][Full Text] [Related]
59. Differentiation of Y79 retinoblastoma cells induced by succinylated concanavalin A. Seigel GM; Notter MF Cell Growth Differ; 1993 Jan; 4(1):1-7. PubMed ID: 8424902 [TBL] [Abstract][Full Text] [Related]
60. [Regulative effects of bailong and Hexamethylene bisacetamide on growth and phenotype of human gastric cancer cells in cell cycle]. Li BY; Liang YY; Wang DS Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 May; 21(5):354-8. PubMed ID: 12577421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]